In a little-noticed announcement in October 2017, Health Canada signalled its intention to raise the fees that drug makers will have to pay when they want to get a new medication on the market.
These user fees currently fund about 50 per cent of Health Canada’s operating budget for regulating prescription drugs. Health Canada wants to increase that to 90 per cent. In addition, it will rebate 25 per cent of that fee if it fails to review new drug applications within an established period of time.
Read more at Toronto Star
Leave a Reply